➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Avelumab - Biologic Drug Details

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for avelumab

Tradenames:	1
Patents:	37
Applicants:	1
BLAs:	2
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for avelumab

Recent Clinical Trials for avelumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Breast Cancer Now	Phase 1
Royal Marsden NHS Foundation Trust	Phase 1
Institut Paoli-Calmettes	Phase 2

See all avelumab clinical trials

Patent Text Search: US Patents for avelumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial		2039-02-26	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	Biomed Valley Discoveries, Inc. (Kansas City, MO)	2035-06-29	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2032-08-14	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	Yeda Research and Development Co. Ltd. (Rehovot, IL)	2034-03-12	RX	Orphan	search
Emd Serono Inc	BAVENCIO	avelumab	INJECTABLE;INJECTION	761049	001	2017-04-25	Start Trial	Yeda Research and Development Co. Ltd. (Rehovot, IL)	2034-03-12	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for avelumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	2008542194	Start Trial
China	110392580	Start Trial
European Patent Office	1874358	Start Trial
Hong Kong	1253235	Start Trial
Mexico	2018013509	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Baxter

McKesson

Moodys

Express Scripts

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.